evorion biotechnologies GmbH
www.evorion.deA pioneer in functional phenomics, evorion biotechnologies offers a proprietary multiparametric platform to characterize thousands of cell-cell interactions at single-cell resolution. Current single-cell multi-omics technologies are an invaluable tool for biological research and precision medicine but fail to directly link a single cell's multi-omics data to changes in its functional phenotype over time. This is where our innovative chip-based technology excels. For the first time, researchers can simultaneously analyze multiple phenotypes (cellular functions, intracellular protein expression, surface, and secreted protein profiles) and the cellular interactions of thousands of cell pairs in a highly parallelized manner. They can then couple those insights directly to each cell’s underlying genetic and transcriptional makeup, merging functional phenotypes with multi-omics data. Our technologies and services are designed to comprehensively analyze biological systems over time and space, and at the resolution of the smallest unit of life. We aim to improve human health by answering unresolved questions with high-end tools and services that reveal novel single-cell mechanistic insights in the field of cell-based therapies, oncology, infectious disease, immunology, and regenerative medicine. Partnering with academia and industry, we enable the research breakthroughs today that will translate to the therapies of tomorrow.
Read moreA pioneer in functional phenomics, evorion biotechnologies offers a proprietary multiparametric platform to characterize thousands of cell-cell interactions at single-cell resolution. Current single-cell multi-omics technologies are an invaluable tool for biological research and precision medicine but fail to directly link a single cell's multi-omics data to changes in its functional phenotype over time. This is where our innovative chip-based technology excels. For the first time, researchers can simultaneously analyze multiple phenotypes (cellular functions, intracellular protein expression, surface, and secreted protein profiles) and the cellular interactions of thousands of cell pairs in a highly parallelized manner. They can then couple those insights directly to each cell’s underlying genetic and transcriptional makeup, merging functional phenotypes with multi-omics data. Our technologies and services are designed to comprehensively analyze biological systems over time and space, and at the resolution of the smallest unit of life. We aim to improve human health by answering unresolved questions with high-end tools and services that reveal novel single-cell mechanistic insights in the field of cell-based therapies, oncology, infectious disease, immunology, and regenerative medicine. Partnering with academia and industry, we enable the research breakthroughs today that will translate to the therapies of tomorrow.
Read moreCountry
City (Headquarters)
Münster
Industry
Employees
11-50
Founded
2017
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chairman of the Supervisory Board
Email ****** @****.comPhone (***) ****-****Chairman of the Supervisory Board
Email ****** @****.comPhone (***) ****-****
Technologies
(5)